Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - deCODE genetics, Inc. (NasdaqNM:DCGN)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials
Recent Events
Aug 15Conference call: deCODE Genetics Earnings (Q2 2001)
Aug 15Earnings Announcement
Location
Lynghals 1
Reykjavik, Iceland
Phone: (354) 570-1900
Fax: (354) 570-1901
Email: ir@decode.is
Employees (last reported count): 400
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Investor Relations
 ·Products & Services
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 43%
·Institutional: 15% (26% of float)
(52 institutions)
·Net Inst. Selling: 49.0K shares (+0.73%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
deCODE genetics, Inc. is a genomics and health informatics company that is developing products and services for the healthcare industry. The Company develops and applies modern informatics technology to discover new knowledge about health and disease through data-mining. The Company's approach to the discovery of healthcare knowledge brings together three key types of anonymous population data derived from the Icelandic nation, including information from the healthcare system, information about relationships among individuals covered by this system and associated molecular genetics data. The Company's business model is based on four sets of information. These include genealogy records of almost all living Icelanders and most of their ancestors for whom records exist; genotype data from consenting Icelanders; the Icelandic Health Sector Database, and other public and proprietary data to which the Company has access.
More from Market Guide: Expanded Business Description

Financial Summary
deCode genetics, Inc. develops gene and drug target discovery, database and information technology products and services for the healthcare industry using human genetics by finding genes that are involved in diseases. For the six months ended 6/01, revenues rose 33% to $11.2 million. Net loss applicable to Common rose 17% to $28.4 million. Revenues reflect an increase in the research collaboration agreement. Higher loss reflects an increase in personnel-related expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Kari Stefansson, 52
Pres, CEO, Chairman
$307K
Terrance McGuire, 45
Vice Chairman, Assistant Sec.
--  
Hannes Smarason, 33
Exec. VP and Sr. Bus. and Fin. Officer
226K
Axel Nielsen, 35
VP-Fin., Treasurer
--  
Sigurour Bjornsson, 37
VP, Corp. Devel.
132K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:DCGNAs of 31-Aug-2001
Price and Volume
52-Week Low
on 16-May-2001
$5.28 
Recent Price$7.15 
52-Week High
on 29-June-2001
$31.00 
Daily Volume (3-month avg)125.0K
Daily Volume (10-day avg)30.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-74.0%
52-Week Change
relative to S&P500
-65.1%
Share-Related Items
Market Capitalization$323.1M
Shares Outstanding45.2M
Float25.8M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$4.25 
Earnings (ttm)-$1.01 
Earnings (mrq)-$0.28 
Sales (ttm)$0.58 
Cash (mrq)$3.42 
Valuation Ratios
Price/Book (mrq)1.68 
Price/EarningsN/A 
Price/Sales (ttm)12.31 
Income Statements
Sales (ttm)$24.3M
EBITDA (ttm)-$37.4M
Income available to common (ttm)-$42.8M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-21.32%
Return on Equity (ttm)-28.98%
Financial Strength
Current Ratio (mrq)6.20 
Debt/Equity (mrq)0.02 
Total Cash (mrq)$154.6M
Short Interest
As of 8-Aug-2001
Shares Short425.0K
Percent of Float1.6%
Shares Short
(Prior Month)
552.0K
Short Ratio5.59 
Daily Volume76.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Some event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.